Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corporation (NMTC)
Filing Type: Form 8-K (Current Report)
Report Date: February 17, 2026
Reporting Period: Fiscal quarter ended December 31, 2025
This filing serves as a notification that the Company issued a press release announcing its financial results for the quarter ended December 31, 2025. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. The filing states that the detailed results are contained in the press release (Exhibit 99.1), which is incorporated by reference but not included in the text provided.
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release regarding Q4 2025 results but does not include the content of that commentary.
Guidance and Outlook: Not provided in filing text.
Risks and Contingencies: Not provided in filing text.
Unusual Items: Not provided in filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 17, 2026) for actual revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the press release.
- Check for any updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the status of the Company's cash position and liquidity runway as detailed in the full financial report.